Literature DB >> 26823760

Mechanism of IFN-γ in regulating OPN/Th17 pathway during vascular collagen remodeling of hypertension induced by ANG II.

Lei Jiang1, Pengcheng He1, Yong Liu1, Jiyan Chen1, Xuebiao Wei1, Ning Tan1.   

Abstract

More and more researches show that hypertensive vascular remodeling is closely related to the imbalance of immune system in recent years. IFN-γ is natural protein with the function of immune regulation and has resistance effect on vascular remodeling. However, the mechanism of IFN-γ is to be defined. This paper is to explore the mechanism of IFN-γ in regulating OPN/Th17 pathway. In this research, animal models of vascular collagen remodeling were established by inducing hypertensive mice with ANG II. There was no statistical significance when the systolic blood pressures and the percentages of wall thickness/lumen diameter in both groups of WT + AngII + IFN-γ and WT + PBS were compared (P=0.219>0.05, P=0.118>0.05). The concentration of serum precollagen-type I and III and their ratio in WT + AngII + IFN-γ group were decreased after the IFN-γ being given (P<0.01). Expression of OPN within tissue in WT + Ang II group was relatively high, but lowered after treated by IFN-γ. Th17 cell ratio was decreased in WT + AngII + IFN-γ group (P<0.01). Expressions of RORα and RORγt mRNA within Th17 cell were decreased (P<0.01). The content of IL-23 in WT + AngII + IFN-γ group was increased, while IL-10 and TGF-β decreased. It has proved that IFN-γ can regulate the hypertensive vascular collagen remodeling induced by ANG II, lower the systolic pressure and reduce the pathological damage of vascular collagen remodeling and the collagen synthesis. The mechanism may that the differentiation of Th17 is inhibited by suppressing the OPN expression and regulating the secretion of inflammatory cytokines.

Entities:  

Keywords:  ANG II; IFN-γ; OPN/Th17; hypertension; vascular collagen remodeling

Mesh:

Substances:

Year:  2015        PMID: 26823760      PMCID: PMC4713546     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  Requirement for RORgamma in thymocyte survival and lymphoid organ development.

Authors:  Z Sun; D Unutmaz; Y R Zou; M J Sunshine; A Pierani; S Brenner-Morton; R E Mebius; D R Littman
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

2.  T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity.

Authors:  Anne R Gocke; Petra D Cravens; Li-Hong Ben; Rehana Z Hussain; Sara C Northrop; Michael K Racke; Amy E Lovett-Racke
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

3.  Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.

Authors:  H A Arafat; E Lada; A K Katakam; N Amin
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-11       Impact factor: 2.949

4.  Osteopontin (OPN) improves risk stratification in pulmonary hypertension (PH).

Authors:  Mark Rosenberg; F Joachim Meyer; Ekkehard Gruenig; Tibor Schuster; Matthias Lutz; Dirk Lossnitzer; Rita Wipplinger; Hugo A Katus; Norbert Frey
Journal:  Int J Cardiol       Date:  2012-01-20       Impact factor: 4.164

Review 5.  [Research progress of Treg and Th17 cells in pulmonary inflammation and fibrosis].

Authors:  Qing Cai; Chunhui Ni
Journal:  Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi       Date:  2014-01

6.  Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice.

Authors:  Mesia M Steed; Neetu Tyagi; Utpal Sen; Dale A Schuschke; Irving G Joshua; Suresh C Tyagi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-25       Impact factor: 5.464

7.  Foxp3+ regulatory T cells play a protective role in angiotensin II-induced aortic aneurysm formation in mice.

Authors:  Keiko Yodoi; Tomoya Yamashita; Naoto Sasaki; Kazuyuki Kasahara; Takuo Emoto; Takuya Matsumoto; Tomoyuki Kita; Yoshihiro Sasaki; Taiji Mizoguchi; Tim Sparwasser; Ken-ichi Hirata
Journal:  Hypertension       Date:  2015-01-19       Impact factor: 10.190

8.  Inhibition of smooth muscle cell proliferation by a chemically modified tetracycline.

Authors:  Markus J Leskinen; Kari K Eklund; Timo Sorsa; Lorne M Golub; Petri T Kovanen; Ken A Lindstedt
Journal:  Coron Artery Dis       Date:  2007-12       Impact factor: 1.439

9.  The Potentiation of IFN-γ and Induction of Cytotoxic Proteins by Pegylated IL-10 in Human CD8 T Cells.

Authors:  Ivan Ho Chan; Victoria Wu; Melissa Bilardello; Elliot Mar; Martin Oft; Peter Van Vlasselaer; John Brian Mumm
Journal:  J Interferon Cytokine Res       Date:  2015-08-26       Impact factor: 2.607

Review 10.  Th17 cells in the setting of Aspergillus infection and pathology.

Authors:  Teresa Zelante; Silvia Bozza; Antonella De Luca; Carmen D'Angelo; Pierluigi Bonifazi; Silvia Moretti; Gloria Giovannini; Francesco Bistoni; Luigina Romani
Journal:  Med Mycol       Date:  2008-06-04       Impact factor: 4.076

View more
  2 in total

1.  ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.

Authors:  Chuanming Xu; Fei Wang; Yanting Chen; Shiying Xie; Danielle Sng; Bruno Reversade; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16

Review 2.  The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension.

Authors:  Cassandra M Moshfegh; Adam J Case
Journal:  Antioxid Redox Signal       Date:  2020-04-30       Impact factor: 8.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.